A detailed history of Eam Investors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Eam Investors, LLC holds 58,764 shares of PRCT stock, worth $5.72 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
58,764
Previous 58,660 0.18%
Holding current value
$5.72 Million
Previous $3.58 Million 31.37%
% of portfolio
0.81%
Previous 0.64%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $5,856 - $8,838
104 Added 0.18%
58,764 $4.71 Million
Q2 2024

Aug 12, 2024

BUY
$45.73 - $69.19 $2.68 Million - $4.06 Million
58,660 New
58,660 $3.58 Million
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $244,542 - $400,844
-7,914 Reduced 13.8%
49,430 $2.05 Million
Q2 2022

Aug 12, 2022

BUY
$29.23 - $44.45 $1.68 Million - $2.55 Million
57,344 New
57,344 $1.88 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.34B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.